NIAID HIV Language Guide
January 24, 2025This guide includes language suggestions for communicating about HIV and related topics.
Patients With HIV May Have High Prevalence of Long COVID
January 15, 2025The prevalence of long COVID was high in patients living with HIV, according to a review published in eClinicalMedicine.
Recommendations for Incorporating Geriatrics Into HIV Care Include Attention to Both Body and Mind
December 16, 2024Of the nearly 1.1 million people living with HIV in the United States in 2022, an estimated 54% were over 50 years old, according to the Centers for Disease Control and Prevention (CDC). Yet we are not doing enough to meet the needs of this population: A recent CDC study found that the country was on pace to miss all of its 2025 goals for improving the quality of life for people living with HIV age 50 and older.
Nearly 20% of New HIV Diagnoses Occur Among Older Adults
December 10, 2024Patients aged 50 and older who were newly diagnosed with HIV often reported heterosexual transmission and were more often women when compared with those younger than 50, according to an analysis of patients in New York State that was published in JAIDS.
Resource Guide: HIV/HCV Health and Housing Collaborative
April 8, 2024HealthHIV’s HIV/HCV Health and Housing’s 2023 Resource Guide was developed throughout a year-long technical assistance project with eight organizations working to increase their HIV/HCV screening and care capacity for their clients experiencing homelessness. The resources in this document provide insight into HIV/HCV care for people experiencing homelessness in a variety of settings and with a variety of populations.
PDAB Action Steps for Patients
April 4, 2024Patients looking to contribute to the conversation about drug affordability and Upper Payment Limits (UPLs) can start here.
PDAB: Balancing the Scale
The Role of PDABs in Drug Pricing and Healthcare Stakeholder Impacts
Considerations and Implications of PDABs and Their Impact on 340Bs
Prescription Drug Affordability Boards (PDABs) are designed to help reduce the costs of prescription medications in 11 states where they currently exist (legislation pending in 13 more states).
Prescription Drug Affordability Boards (PDABs) and Upper Payment Limits (UPLs) Impact on Patients, Drug Pricing, and Innovation
This HealthHIV Advocacy paper explores the function of Prescription Drug Affordability Boards (PDABs) in managing prescription drug costs, considering perspectives of patients, providers, and payers to ensure equitable access to vital medications while controlling healthcare expenses.
Aging with Pride: National Health, Aging, and Sexuality/Gender Study
February 5, 2024This landmark study is the first federally-funded longitudinal national project designed to better understand the aging, health, and well-being of sexual and gender diverse midlife and older adults.
Integrating Frailty and Functional Outcomes into Clinical Trials
Considerations of frailty and functional outcomes for better integration and representation of aging patients in clinical trials.
Inflamm-aging: Effects of Chronic Inflammation with HIV
Advances in Antiretroviral therapy (ART) allow people with HIV to live longer with fewer medications. Join us as Dr. Peter Hunt details the connection between chronic inflammation and HIV infection and discusses care considerations and emerging research.
